academic article

• Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy..  International journal of radiation oncology, biology, physics.  110:124-136. 2021
• A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases..  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.  32:1834-1846. 2019
• A comprehensive gene-environment interaction analysis in Ovarian Cancer using genome-wide significant common variants..  International journal of cancer.  144:2192-2205. 2019
• Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk..  Cancer research.  79:505-517. 2019
• Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. 2017
• Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes..  Clinical cancer research : an official journal of the American Association for Cancer Research.  23:3794-3801. 2017
• Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci..  British journal of cancer.  116:524-535. 2017
• PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS..  Journal of medical genetics.  53:800-811. 2016
• Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study..  International journal of epidemiology.  45:1619-1630. 2016
• Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus..  Nature communications.  7:-. 2016
• Assessing the genetic architecture of epithelial ovarian cancer histological subtypes..  Human genetics.  135:741-756. 2016
• Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types..  Cancer discovery.  :-. 2016
• A targeted genetic association study of epithelial ovarian cancer susceptibility..  Oncotarget.  7:7381-7389. 2016
• Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk..  Genetic epidemiology.  :-. 2015
• TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer..  Nucleic acids research.  43:6945-6958. 2015
• Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk..  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.  :-. 2015
• Shared genetics underlying epidemiological association between endometriosis and ovarian cancer..  Human molecular genetics.  :-. 2015
• Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study..  Gynecologic oncology.  136:542-548. 2015
• Identification of six new susceptibility loci for invasive epithelial ovarian cancer. 2015
• Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer..  Nature communications.  6:-. 2015
• Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. 2015
• Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer..  Cancer research.  74:3084-3091. 2014
• Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status..  Scientific reports.  4:-. 2014
• Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer..  BMC medical genomics.  7:-. 2014
• APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma..  Cancer research.  73:7222-7231. 2013
• Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel..  Human molecular genetics.  22:3038-3047. 2013
• Assessment of hepatocyte growth factor in ovarian cancer mortality..  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.  20:1638-1648. 2011
• Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers..  PloS one.  6:-. 2011